Dual PI3K/mTOR inhibition in PIK3CA mutant pancreatic cancers

被引：0
|
作者：
Payne, Susan [1 ]
Depke, Mitchell [1 ]
Yueh, Alex [1 ]
Sharick, Joseph T. [2 ]
Favreau, Peter F. [2 ]
Pasch, Cheri A. [1 ]
Clipson, Linda [1 ]
Matkowskyj, Kristina A. [1 ]
Skala, Melissa [2 ]
Deming, Dustin A. [1 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] Morgridge Inst Res, Madison, WI USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-3472
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3472
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Activation of the PI3K/AKT pathway and PIK3CA mutations in Merkel cell carcinoma
    Hafner, C.
    Houben, R.
    Baeurle, A.
    Landthaler, M.
    Becker, J. C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2010, 8 (09): : 739 - 739
  • [42] Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
    Vasan, Neil
    Razavi, Pedram
    Johnson, Jared L.
    Shao, Hong
    Shah, Hardik
    Antoine, Alesia
    Ladewig, Erik
    Gorelick, Alexander
    Lin, Ting-Yu
    Toska, Eneda
    Xu, Guotai
    Kazmi, Abiha
    Chang, Matthew T.
    Taylor, Barry S.
    Dickler, Maura N.
    Jhaveri, Komal
    Chandarlapaty, Sarat
    Rabadan, Raul
    Reznik, Ed
    Smith, Melissa L.
    Sebra, Robert
    Schimmoller, Frauke
    Wilson, Timothy R.
    Friedman, Lori S.
    Cantley, Lewis C.
    Scaltriti, Maurizio
    Baselga, Jose
    CANCER RESEARCH, 2020, 80 (16)
  • [43] Determinants of sensitivity to PI3K inhibitors in PIK3CA wildtype gastric tumor cells
    Chong, Mei Ling
    Bhattacharya, Bhaskar
    Voon, Dominic
    Ko, King Xin
    Low, Hong Hui
    Chang, Ti Ling
    Wu, Mengchu
    Tan, Patrick Boon Ooi
    Loh, Marie Chiew Shia
    Benoukraf, Touati
    Huynh The Hung
    Politz, Oliver
    Liu, Ningshu
    Soong, Richie Chuan Teck
    CANCER RESEARCH, 2015, 75
  • [44] Targeting glutamine addiction of PIK3CA mutant colorectal cancers
    Zhao, Yiqing
    CANCER RESEARCH, 2017, 77
  • [45] The PI3K inhibitor, taselisib, has a unique mechanism of action that leads to enhanced potency in PIK3CA mutant models
    Song, Kyung W.
    Edgar, Kyle A.
    Kirkpatrick, Donald S.
    Phu, Lilian
    Schmidt, Stephen
    Nannini, Michelle
    Hong, Rebecca
    Cheng, Eric
    Crocker, Lisa
    Young, Amy
    Sampath, Deepak
    Friedman, Lori
    CANCER RESEARCH, 2017, 77
  • [46] Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway
    Chen, Zhihang
    Wang, Chun
    Dong, Hao
    Wang, Xing
    Gao, Feng
    Zhang, Sen
    Zhang, Xiaolong
    MOLECULAR MEDICINE, 2020, 26 (01)
  • [47] Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway
    Zhihang Chen
    Chun Wang
    Hao Dong
    Xing Wang
    Feng Gao
    Sen Zhang
    Xiaolong Zhang
    Molecular Medicine, 2020, 26
  • [48] The PI3K inhibitor, taselisib, has enhanced potency in PIK3CA mutant models through a unique mechanism of action
    Friedman, L. S.
    Edgar, K. A.
    Song, K.
    Schmidt, S.
    Kirkpatrick, D. S.
    Phu, L.
    Nannini, M. A.
    Hong, R.
    Cheng, E.
    Crocker, L.
    Young, A.
    Sampath, D.
    CANCER RESEARCH, 2017, 77
  • [49] TRAF6 interacts with and ubiquitinates PIK3CA to enhance PI3K activation
    Wang, Zixi
    Liu, Yuxiang
    Huang, Song
    Fang, Min
    FEBS LETTERS, 2018, 592 (11): : 1882 - 1892
  • [50] Analysis of PIK3CA mutations and PI3K pathway proteins in advanced gastric cancer
    Ito, Chie
    Nishizuka, Satoshi S.
    Ishida, Kazuyuki
    Uesugi, Noriyuki
    Sugai, Tamotsu
    Tamura, Gen
    Koeda, Keisuke
    Sasaki, Akira
    JOURNAL OF SURGICAL RESEARCH, 2017, 212 : 195 - 204
12345